Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Selvaluxmy Ganeshrajah"'
Autor:
Hemavathi Dhandapani, Hascitha Jayakumar, Abirami Seetharaman, Shirley Sunder Singh, Selvaluxmy Ganeshrajah, Nirmala Jagadish, Anil Suri, Rajkumar Thangarajan, Priya Ramanathan
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background Dendritic cell (DC)-based immunotherapy is capable of activating the immune system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the tumor. However, major limitations are the availability of autologo
Externí odkaz:
https://doaj.org/article/a0cb136a31eb4bc8be9f67942d0997f1
Autor:
Umesh Mahantshetty, Shivakumar Gudi, Roshni Singh, Ajay Sasidharan, Supriya (Chopra) Sastri, Lavanya Gurram, Dayanand Sharma, Selvaluxmy Ganeshrajah, Janaki MG, Dinesh Badakh, Abhishek Basu, Francis James, Jamema Swamidas, Thayalan Kuppuswamy, Rajendra Bhalavat
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 11, Iss 4, Pp 293-306 (2019)
Brachytherapy (BT) for locally advanced cervical cancer is vital for optimal outcomes. There is heterogeneity in brachytherapy treatment practice for cervical cancer across India. In an attempt to standardize various processes involved in cervical ca
Externí odkaz:
https://doaj.org/article/df989047a7ef46d19ca789c4917658ab
Autor:
Hascitha, Jayakumar, Priya, Ramanathan, Jayavelu, Subramani, Dhandapani, Hemavathi, Selvaluxmy, Ganeshrajah, Sunder Singh, Shirley, Rajkumar, Thangarajan
Publikováno v:
In Clinical Biochemistry August 2016 49(12):919-924
Publikováno v:
Psycho-oncologyREFERENCES. 31(10)
Cervical cancer is the second most common cancer among women in India. Medical advancements have led to increased survival. However, sexuality and sexual concerns remain as major worries of patients after treatment. This study aims to understand the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8c6f171d33cd770979a12f94227031e
https://pubmed.ncbi.nlm.nih.gov/35986590
https://pubmed.ncbi.nlm.nih.gov/35986590
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hascitha, Jayakumar, Abirami, Seetharaman, Shirley, Sunder Singh, Hemavathi, Dhandapani, Jayavelu, Subramani, Selvaluxmy, Ganeshrajah, Rajkumar, Thangarajan, Priya, Ramanathan
Publikováno v:
Journal of reproductive immunology. 149
The over expression of Indoleamine 2, 3-Dioxygenase (IDO1), an immune checkpoint inhibitor, is well known in cervical cancer. However, its association with chemokine signals promoting cellular infiltration in the cervical tumor microenvironment, is u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62661b7e4b792243d88ed46eff7bb01f
https://pubmed.ncbi.nlm.nih.gov/34856521
https://pubmed.ncbi.nlm.nih.gov/34856521
Autor:
Abirami Seetharaman, Hemavathi Dhandapani, Priya Ramanathan, Hascitha Jayakumar, Shirley Sunder Singh, Selvaluxmy Ganeshrajah, Rajkumar Thangarajan
Publikováno v:
Journal of Gynecologic Oncology
Objective Dendritic cells (DCs) are administered as immunotherapeutic adjuvants after the completion of standard treatment in most settings. However, our Phase I trial indicated that one patient out of four, who received autologous tumor lysate-pulse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db546fc15f33266720754dad9bd81bb0
http://europepmc.org/articles/PMC8192235
http://europepmc.org/articles/PMC8192235
Autor:
Hemavathi, Dhandapani, Hascitha, Jayakumar, Abirami, Seetharaman, Shirley Sunder, Singh, Selvaluxmy, Ganeshrajah, Nirmala, Jagadish, Anil, Suri, Rajkumar, Thangarajan, Priya, Ramanathan
Publikováno v:
Cancer Cell International
Background Dendritic cell (DC)-based immunotherapy is capable of activating the immune system and in particular tumor-specific cytotoxic T lymphocytes (CTLs) to eradicate the tumor. However, major limitations are the availability of autologous tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5e8dc58a97411d6fd6ca6ce6e882f9cf
https://pubmed.ncbi.nlm.nih.gov/34493268
https://pubmed.ncbi.nlm.nih.gov/34493268
Autor:
Abirami Seetharaman, Hascitha Jayakumar, Rajkumar Thangarajan, Hemavathi Dhandapani, Selvaluxmy Ganeshrajah, Jayavelu Subramani, Shirley Sunder Singh, Priya Ramanathan
Publikováno v:
Journal of Reproductive Immunology. 149:103454
The over expression of Indoleamine 2, 3-Dioxygenase (IDO1), an immune checkpoint inhibitor, is well known in cervical cancer. However, its association with chemokine signals promoting cellular infiltration in the cervical tumor microenvironment, is u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2093169697eeaaef9758aba0a388d4b9
https://doi.org/10.1016/j.jri.2021.103454
https://doi.org/10.1016/j.jri.2021.103454
Autor:
Priya Ramanathan, Rajkumar Thangarajan, Selvaluxmy Ganeshrajah, Rajalekshmi Kamalalayam Raghanvan, Shirley Sundar Singh
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 15:5909-5916
Human papillomavirus infection (HPV) and HPV related immune perturbation play important roles in the development of cervical cancer. Since mature dendritic cells (DCs) are potent antigen-presenting cells (APC), they could be primed by HPV antigens ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90e8c5dcd9e473ee4ba1f9aa4a39fea0
https://doi.org/10.7314/apjcp.2014.15.14.5909
https://doi.org/10.7314/apjcp.2014.15.14.5909